2. COSMECEUTICALS
“A product with an activity that is intended to
treat or prevent a (mild) skin (abnormality)”
– In Europe and Japan, cosmeceuticals can be
regarded as a subclass of cosmetics;
however, in the United States cosmeceuticals
can only be regarded as a subclass of drugs.
3. CHARACTERIZATION OF
COSMACEUTICALS
Cosmeceuticals could be characterized as follows:
1- The product has pharmaceutical activity and can
be used on normal or near-normal skin.
2- The product should have a defined benefit for
minor skin disorders (cosmetic indication).
3- As the skin disorder is mild the product should
have a very low-risk profile
5. 1-PHOTOAGING AGENTS
– Aging and photoaging of the skin are now
well-accepted concepts, aging skin was
accepted as an inevitable, irreversible, and
trivial consequence of getting old.
– Photoaging begins at a very early time point,
even in infancy, as a result of repetitive,
chronic exposure of the skin to ultraviolet
radiation.
6. The clinical condition of
photoaging:
1- The clinical condition of photoaging:
– Cosmetic Deficits : The subject or patient
complains that they look ‘‘old’’ to themselves
and others.
– They note that their skin is rough, dry,
wrinkled, and that their face and hands, in
particular, have numbers of variously colored
flat spots.
7. The clinical condition of
photoaging:
– Clinical Presentations: Photoaging is most
frequently progressive, yet modified by both
environmental exposure and genetics.
– The clinical presentation of photodamage include
Diverse
pigmentary
alterations
Rough texture
Sallow
complexion
Thinned skin
easily
traumatized
Sensory
decrease
8. Cosmeceutical Testing:
2- Cosmeceutical Testing:
– Cosmeticeutical testing is critical for accurate,
precise, consistent, reproducible, and valid
observations in photoaging.
– The optimum trial for pharmaceutical, and to
some extent cosmeceutical, purposes is double-
blind, placebo (vehicle)-controlled, multicenter,
and frequently, for the chronic process of
photoaging, of at least several months’ duration.
9. Products potentially classed
as cosmeceuticals:
3- Products potentially classed as cosmeceuticals:
a) Moisturizers
– Simple occlusion of the skin, with a ‘‘moisturizer’’
such as petrolatum, has definite effects on skin
structure and probably on function.
– Older or photodamaged skin is frequently perceived
as ‘‘dry,’’ there is substantial evidence that TEWL is
actually decreased in chronologically aged skin.
11. Products potentially classed
as cosmeceuticals:
– Moisturizers and emollients may exert their
positive effects in several ways.
Simple occlusion effects may acutely allow
retention of more water in the skin and
acutely lead to lowered TEWL.
Healing of damaged stratum corneum and
replacement of intercellular lipids may
reestablish normal barrier function and allow
normalization of TEWL.
12. Products potentially classed
as cosmeceuticals:
b) Retinoids
– Retinoids, with pleotropic biological
effects including modulation of epidermal
cell differentiation and sebocyte
dedifferentiation.Have been extensively
studied and have, in a way, become the
prototypic cosmeceutical by which others
are judged in treatment of photoaging.
13. Products potentially classed
as cosmeceuticals:
– Different retinoid used are
Isotretinoin has also been adequately documented in
double-blind, vehicle controlled trials to improve the
same parameters of photoaging.
Adapalene has been proven effective in treatment of
acne.
Tazarotene, another recently studied retinoid, has
been shown to be effective in psoriasis and acne will
likely be effective in photoaging
14. Products potentially classed
as cosmeceuticals:
Retinol, the prototypic retinoid, is the
alcohol of retinoic acid and has been
shown to be somewhat active in animal
models of photodamage.
15. Products potentially classed
as cosmeceuticals:
c) Hormones and Vitamins
– Hormone and vitamin deficiencies adversely affect the skin
and as many of the skin functions and structures be
affected by hormonal or vitamin treatment.
– Attention focused on the therapeutic use of androgen,
thyroid, or growth hormones topically applied in
photoaging.
16. 2-PEELING AGENTS-
HYDROXYACIDS
– Hydroxyacids are organic carboxylic acids classified into the
α- and β-types (AHA and BHA) according to their molecular
structure.
– Both AHAs and BHAs are used worldwide and most
probably for centuries as active dermatological drugs and
cosmetic ingredients.
17. a) Biological activities of hydroxyacids:
– Both AHAs and BHAs exert indisputable direct effects
on the stratum corneum, at least when it is affected
by xerosis, ichthyosis, and analogous conditions.
– Comedonal hyperkeratosis in acne-prone subjects
might also be improved by the same compounds.
– In the field of tumors, benign keratoses and viral
warts may also be affected by high-concentration
formulations.
18. – The efficacy is largely related to the pH-related chemical
burn. Such caustic effect is also induced in order to realize
AHA skin peeling.
– Salicylic acid is the reference BHA used since the early days
of dermatology to improve xerotic conditions.
19. b) Caustic effects:
– When applied to the skin in high concentration, AHAs cause
necrosis and detachment of keratinocytes leading to
epidermolysis .
– Such injury is a chemical peeling depending primarily upon
the disruption of the skin pH.
20. 3-SEBUM REGULATORS
– Sebaceous glands are generally associated with hair
follicles.
– Human sebum from isolated sebaceous glands consists
mainly of squalene, wax ,esters, and triglycerides with
small proportions of cholesterol and cholesterolesters.
21. a) Sebum in health:
– In hairy mammals, sebum serves two clear functions.
– First, it is a water repellent on the fur, which is clearly
advantageous for aquatic mammals and for mammals living
in moist environments.
22. – Second, 7-dehydrocholesterol secreted from the
sebaceous glands onto the skin surface is photochemically
converted to pre vitamin D, which is then converted to
vitamin D in a temperature-dependent, non enzymatic
reaction.
– Sebum no doubt contributes a degree of lubrication to the
skin surface, and it has sometimes been suggested that dry
skin results from insufficient sebum production.
23. b) Sebum in disease:
– ACNE
There is a clear, positive correlation between the occurrence
and severity of acne and the sebum secretion rate.
It has been suggested that the development of acne may
result from essential fatty acid deficiency localized to the
follicular epithelium.
Reduction of the sebum secretion rate is therapeutic for acne.
This can be achieved by oral administration of retinoids,
estrogen, or antiandrogens.
24. 4-HAIR GROWTH
ENHANCERS
– Hair has played a significant role in the lives of people.
– Both men and women regard an abundance of hair as
ideal, providing them with positive self-image attributes
such as beauty, strength, youthfulness, and confidence.
25. Hair growth enhancers
available in the market.
– Minoxidil topical solution 2%, became the first clinically
proved, safe, and effective hair-growth stimulant after it
was discovered that its active ingredient (minoxidil) caused
hypertrichosis when taken orally for hypertension.
– The 2% concentration of minoxidil topical solution became
available in 1986 for men and in 1991 for women.
– Finasteride was recently introduced into several countries
including the united states as a prescription product for
males only.
26. Conditions in which growth
enhancers are used.
Androgenetic alopecia
– Androgenetic alopecia is the most common type of hair
loss in humans.
– Androgenetic alopecia affects approximately 50% of men
over 40 years of age and may also affect just as many
women
27. Conditions in which growth
enhancers are used.
Alopecia areata
– Alopecia areata is a nonscarring, reversible hair disorder
that can cause hair loss anywhere on the body.
– It appears to affect males and females equally. Although
alopecia areata can occur at any age, its onset is before the
age of 20 years in about one-half of the cases.
28. Conditions in which growth
enhancers are used.
Diffuse alopecia:
– Patients afflicted with diffuse alopecia typically complain of
hair loss all over the scalp not just in the areas usually seen
in androgenetic alopecia.
– One of the most common causes of diffuse alopecia,
chemotherapy, minoxidil topical solution may have utility in
reducing the duration of the induced hair loss.
29. Future of hair growth
therapy
– The future for hair growth research and potential forms of
treatment is very bright.
– The cross-disciplinary efforts of academia, the
pharmaceutical industry, and clinicians have led to new
understanding of hair growth regulation, both
biochemically and genetically.
30. 5-MOISTURIZERS
– Dry and chapped skin is a very common problem both in
healthy individuals and in patients with skin diseases.
– Dry skin might be connected to some inherited disorders
relating to the structure and function of the epidermis.
31. Moisturizers in relation to skin
structure and water
content
– Moisturizers are expected to increase skin hydration and to
modify the physical and chemical nature of the surface to
one that is smooth, soft, and pliable.
– Smoothing of the surface can be observed immediately
after application of a moisturizer as a result of the filling of
spaces between partially desquamated skin flakes
32. Possible Roles for
Humectants
– Moisturizers often contain low-molecular-weight
substances with water-attracting properties, called
humectants.
– These substances are supposed to penetrate into the skin
and increase the degree of hydration of the SC.
33. Possible Roles for
Humectants
– Despite the widespread use of moisturizers, scant attention
has been paid to their influence on the permeability barrier
of normal skin.
– It may be anticipated that the use of moisturizers on
normal skin will increase the permeability, since increased
hydration of normal skin is known to reduce its diffusional
resistance.
– Hydration may create interfacial defects in the lipid bilayer
caused by phase separation
34. 6-BOTANICAL EXTRACTS
– Natural extracts, whether from animal, botanical, or
mineral origin, have been used as ‘‘active ingredients’’ of
drugs or cosmetics for as long as human history can go.
– Oils, butter, honey, beeswax, lead, and lemon juice were
common ingredients of the beauty recipes from ancient
Egypt.
35. – In the cosmetic industry, the botanical extract is the active
ingredient.
– It may contain hundreds of chemical structures and it has a
proven activity.
Sometimes the
isolation and
purification leads to
a loss in the
biological activity.
36. Origin of botanical extracts
– Botanical extracts have been used for centuries and are
present in today’s products
– There are plant powders for hair coloring (Henne), scrubs
(apricot kernel, corn), or masks (oat flour).
37. Use of Extracts
– They can be topically applied, ingested, or injected,
depending on the intended use and provided absence of
toxicity has been shown.
38. Activity of Extracts
1- Antioxidants:
– Free radicals have been shown to play a major role in sun
damage as well as in aging or in pollution (tobacco, stress).
– They act by degrading the skin structural fibers (collagen,
elastin), cell membranes, DNA, or by creating inflammatory
reactions.
39. Activity of Extracts
Free radical actions can be blocked by the following.
Vegetable oils rich in tocopherols and tocotrienols.
Wheat germ oil and palm Oil are particularly rich in
tocopherols and α-, β-, γ-tocotrienols.
– Ascorbic acid, antioxidant that is also used for many of its
properties.
– Flavonoids, rich extracts from Gingko, are used for their
antioxidant and anti-free-radical properties.
40. Conclusion
– Many other activities of botanical extracts have been
shown and are used in cosmetics or drugs (OTC or
traditional).
– Botanicals are playing an increasingly important role in the
activity and safety of cosmetics; they allow for a renewal of
the source of active ingredients in drugs.
41. 7-TOPICAL RETINOIDS
– The retinoids are a diverse class of pharmacological
compounds, consisting of vitamin A (retinol) and its
naturally occurring and synthetic derivatives.
– Vitamin A generically encompasses retinol (vitamin A
alcohol), retinal (vitamin A aldehyde), and retinoic acid
(vitamin A acid)
42. Clinical uses
– In clinical use, retinoids have established their effectiveness
in treating
Acneiform eruptions (e.g., Isotretinoin),
Disorders of keratinization, such as psoriasis (e.g.,
Acitretin)
Neoplastic processes (e.g., Tretinoin for leukemia,
isotretinoin for squamous cell carcinomas).
43. The main focus of retinoid usage
in cosmeceuticals has been its role
as the mythical ‘‘fountain of youth’’
(i.e.,
reversal of photoaging)
Retinoids, like all drugs, have
adverse effects,
the most infamous one being
teratogenicity.
44. Classification of Retinoids
Generation Retinoid
First generation Tretinoin ,Isotretinoin
Second generation Etretinate
Third generation Arotinoid
Naturally occurring in humans Retinol (vitamin A)
Retinal (vitamin A- aldehyde)
Retinoic Acid
45. The Roles of Naturally
Existing Retinoids
Retinoid Role
Retinol Growth promotion
Differentiation/maintenance of epithelia
Reproduction
Retinal Vision
Retinoic acid Growth promotion
Differentiation/maintenance of epithelia
47. Role in cosmeceuticals
– The major forms of retinoids that may be of significant
interest to the cosmeceutical industry are retinol, retinal,
and possibly, retinoic acid.
– The main role of retinoids in cosmeceuticals are in extrinsic
aging (photoaging).
– Currently, topical retinoic acid is FDA-approved for the
treatment of acne, and in the adjunct treatment of fine
skin wrinkling, skin roughness, and hyperpigmentation due
to photoaging.
48. 8-DEPIGMENTATION
AGENTS
– There are a variety of facial pigmentary disorders
1. Melasma (chloasma)
2. Solar lentigo
3. Pigmented cosmetic dermatitis
4. Melanoma
– Among such diseases, malignant tumors should be diagnosed
and treated properly because some of them are quick to
develop, destructive, or fatal.
– Hyperpigmentation of the face of middle-aged women, is
most common.
50. Evaluation of the treatment
– The evaluation of the treatment of pigmentary disorders of
the face is not easy.
– With melasma, the brown pigmentation fades so slowly
that patients often do not recognize the effects of
depigmentation agents after 6 months of continual, twice-
a-day application.
– The best way to evaluate is to take color photographs of
the faces of melasma patients from three angles—front,
45° right, and 45° left.
51. – When the same camera, flashlight, and color film are used,
the effect of depigmentation agents can surely be
recognized
– First the color of the melasma turns from brown to
yellowish brown or normal skin color, and second, the
contrast at the border of the melasma becomes obscure.
– On the other hand, pattern recognition using color
photographs from the same three angles of the face is
much easier.
52. – Similar evaluation is possible with
• Solar lentigo,
• Ephelid, and
• Pigmented cosmetic dermatitis